📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer models (2021)

First Author: Mehibel M

Attributed to: Manipulation of the Complement Pathway to Increase Radiation Sensitivity and Immune Response funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci146256

PubMed Identifier: 34060485

Publication URI: http://europepmc.org/abstract/MED/34060485

Type: Journal Article/Review

Parent Publication: Journal of Clinical Investigation

Issue: 11

ISSN: 0021-9738